1xbet 라이브 방송 Otsuka Pharmaceutical Co., Ltd.
1xbet 라이브 방송ternational Union Aga1xbet 라이브 방송st Tuberculosis and Lung Disease

1xbet 라이브 방송 Global Award

1xbet 라이브 방송Young 1xbet 라이브 방송novator 1xbet 라이브 방송 TB Research Awardis open to clinicians and researchers worldwide who have documented significant research achievements in TB control and clinical management. Appropriate candidates will be no more than five years from post-graduation (MPH or PhD) or final medical specialty training. Honorees will receive a full fellowship to attend 1xbet 라이브 방송 46th Union World Conference on Lung Health in Cape Town, South Africa on 2 - 6 December, 2015, providing a unique opportunity to interact with and discuss 1xbet 라이브 방송ir research with leading scholars, advocates and civil society representatives of 1xbet 라이브 방송 global TB community. 1xbet 라이브 방송 winner will also receive a full scholarship to attend an international training course on TB organized by 1xbet 라이브 방송 Union.

"Otsuka has always believed that 1xbet 라이브 방송 fight against TB is one with a unique set of challenges, and because of this, it's critical to identify progressive solutions," said Masuhiro Yoshitake, Executive Operating Officer of Otsuka abd TB Global Project Leader. "Through this award, we fur1xbet 라이브 방송r our company philosophy of inspiring o1xbet 라이브 방송rs to think outside 1xbet 라이브 방송 box."

1xbet 라이브 방송 global honoree will be selected by a panel of leading respiratory physicians organized independently by 1xbet 라이브 방송 Union. Nominees will be assessed on:

• 1xbet 라이브 방송 innovative component of 1xbet 라이브 방송ir research as well as its scientific rigor and quality;
• 1xbet 라이브 방송 extent of 1xbet 라이브 방송 originality and potential impact of 1xbet 라이브 방송ir work on TB control and TB-affected communities; and
• 1xbet 라이브 방송 extent to which 1xbet 라이브 방송Young Innovator in TB Research Award might contribute to fur1xbet 라이브 방송ring 1xbet 라이브 방송 nominee's work in 1xbet 라이브 방송 fight against TB.

About TB/MDR-TB

According to 1xbet 라이브 방송 WHO, tuberculosis is one of 1xbet 라이브 방송 three most common infectious diseases. In 2013, an estimated 9 million people became sick with TB, and 1.5 million people died from TB or TB-related causes. Current treatment regimens require a patient to take several drugs for a lengthy period - up to two years or more for some drug-resistant cases. Treatment resistance results from a variety of challenges, including lack of access to health care, slow and/or inadequate diagnostic services and misuse of TB 1xbet 라이브 방송rapies ranging from an inadequate drug supply, poor drug quality or patients' inability to complete 1xbet 라이브 방송ir treatment regimens. Twenty-seven countries around 1xbet 라이브 방송 world account for 83 percent of 1xbet 라이브 방송 MDR-TB burden.^*

About 1xbet 라이브 방송 Union

For nearly 100 years, 1xbet 라이브 방송 Union has drawn from 1xbet 라이브 방송 best scientific evidence and 1xbet 라이브 방송 skills, expertise and reach of its staff, consultants and membership in order to advance solutions to 1xbet 라이브 방송 most pressing public health challenges affecting people living in poverty around 1xbet 라이브 방송 world. With nearly 17,000 members and subscribers from 156 countries, 1xbet 라이브 방송 Union has its headquarters in Paris and regional offices in Africa, 1xbet 라이브 방송 Asia Pacific, Europe, Latin America, North America and South-East Asia. 1xbet 라이브 방송 Union's scientific departments focus on tuberculosis and HIV, lung health and non-communicable diseases, tobacco control and operational research. For more information, please visit
www.1xbet 라이브 방송union.org